multiple electrode platelet aggregometry (mea (Dynabyte GmbH)
Structured Review

Multiple Electrode Platelet Aggregometry (Mea, supplied by Dynabyte GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+electrode+aggregometry/multiple+platelet+function+analyzer/pmc04245259-81-9-14
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry"
Article Title: Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
Journal: PLoS ONE
doi: 10.1371/journal.pone.0114053
Figure Legend Snippet: A: A negative correlation was observed between the PRU value and hematocrit. B: No significant correlation was observed between the MEA ADP assay results and hematocrit. MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test; PRU: P2Y12 reaction units.
Techniques Used:
Figure Legend Snippet: Scatterplots of the VerifyNow P2Y12 (A) and MEA ADP (B) assays according to the presence of anemia. The red line denotes the median value. MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test.
Techniques Used:
Figure Legend Snippet: The overall distribution pattern of each patient was different between the non-anemic (A) and anemic (B) patient groups. MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test; PRU: P2Y12 reaction units.
Techniques Used:
Figure Legend Snippet: A: Correlation analysis between the PRU value and MEA ADP assay results. B: Correlation analysis between the HPRU value and MEA ADP assay results. HPRU: hematocrit-adjusted PRU; MEA ADP: multiple-electrode platelet aggregometry adenosine diphosphate test; PRU: P2Y12 reaction units.
Techniques Used:
Related Articles
other:Article Title: Prospective Trial on the Pharmacokinetics of Clopidogrel in Hemodialysis Patients Article Snippet: Multiple Electrode Aggregometry on a Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo Article Snippet: We used the multiple electrode aggregometry on an Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo. Article Snippet: Whole blood platelet aggregometry We used the multiple electrode aggregometry on an Coagulation:Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo. Article Snippet: .. Therefore, these patients Fig. 2 Results of the platelet aggregation measured by the Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo Article Snippet: .. Fig. 2 Results of the platelet aggregation measured by the Control:Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo. Article Snippet: .. Therefore, these patients Fig. 2 Results of the platelet aggregation measured by the Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo Article Snippet: .. Fig. 2 Results of the platelet aggregation measured by the |